Episode

MAHA News [5.22] Bioengineered Ticks & Alpha Gal, Ebola/Hanta, Forever Chemicals

Podcast
Badlands Media
Published
May 22, 2026
Duration seconds
3033
Processing state
not_requested
Canonical source
https://badlandsmedia.podbean.com/e/maha-news-522-bioengineered-ticks-alpha-gal-ebolahanta-forever-chemicals/
Audio
https://mcdn.podbean.com/mf/web/fze8v4fpw3h76xy3/MAHA_News_May_22_1_9hq9e.mp3
JSON
/v1/public/podcasts/badlands-media-6674661/episodes/maha-news-5-22-bioengineered-ticks-alpha-gal-ebola-hanta-forever-chemicals
Markdown
/podcast/badlands-media-6674661/maha-news-5-22-bioengineered-ticks-alpha-gal-ebola-hanta-forever-chemicals.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/badlands-media-6674661/episodes/maha-news-5-22-bioengineered-ticks-alpha-gal-ebola-hanta-forever-chemicals/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/badlands-media-6674661/maha-news-5-22-bioengineered-ticks-alpha-gal-ebola-hanta-forever-chemicals.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Jordan Sather and Nate Prince dig into a week that felt like a nature documentary gone wrong. Ticks are surging across the Northeast and Midwest, alpha gal syndrome is quietly making red meat allergies a real and growing problem, and a peer reviewed bioethics paper from Western Michigan University actually argues scientists are morally obligated to gene-edit lone star ticks to spread alpha gal and push people away from meat. No, that is not satire. Meanwhile, the WHO and media are still flogging hantavirus and Ebola, and the Trump administration is still not biting. PFAS contamination sits in over 95% of Americans' bloodstreams, and Jordan breaks down where it comes from and how zeolite may help pull it out. RFK scores the largest autism fraud bust in US history, Dr. Oz keeps hammering Medicare and hospice fraud, and TrumpRx quietly adds 600 more generic drugs. Big pharma is apparently starting to sweat, with mass layoffs hitting Pfizer, Merck, Novo Nordisk, and more.